219 related articles for article (PubMed ID: 26088929)
1. Transcription and methylation analyses of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation.
Gaillard C; Tokuyasu TA; Rosen G; Sotzen J; Vitaliano-Prunier A; Roy R; Passegué E; de Thé H; Figueroa ME; Kogan SC
Haematologica; 2015 Aug; 100(8):1064-75. PubMed ID: 26088929
[TBL] [Abstract][Full Text] [Related]
2. Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia.
Gaillard C; Surianarayanan S; Bentley T; Warr MR; Fitch B; Geng H; Passegué E; de Thé H; Kogan SC
Blood Adv; 2018 Oct; 2(19):2462-2466. PubMed ID: 30266821
[TBL] [Abstract][Full Text] [Related]
3. PML-RARalpha initiates leukemia by conferring properties of self-renewal to committed promyelocytic progenitors.
Wojiski S; Guibal FC; Kindler T; Lee BH; Jesneck JL; Fabian A; Tenen DG; Gilliland DG
Leukemia; 2009 Aug; 23(8):1462-71. PubMed ID: 19322209
[TBL] [Abstract][Full Text] [Related]
4. Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation.
Nasr R; Guillemin MC; Ferhi O; Soilihi H; Peres L; Berthier C; Rousselot P; Robledo-Sarmiento M; Lallemand-Breitenbach V; Gourmel B; Vitoux D; Pandolfi PP; Rochette-Egly C; Zhu J; de Thé H
Nat Med; 2008 Dec; 14(12):1333-42. PubMed ID: 19029980
[TBL] [Abstract][Full Text] [Related]
5. Eradication of acute promyelocytic leukemia-initiating cells by PML/RARA-targeting.
Nasr R; de Thé H
Int J Hematol; 2010 Jun; 91(5):742-7. PubMed ID: 20455087
[TBL] [Abstract][Full Text] [Related]
6. Understanding the molecular pathogenesis of acute promyelocytic leukemia.
Lo-Coco F; Hasan SK
Best Pract Res Clin Haematol; 2014 Mar; 27(1):3-9. PubMed ID: 24907012
[TBL] [Abstract][Full Text] [Related]
7. Clearance of PML/RARA-bound promoters suffice to initiate APL differentiation.
Vitaliano-Prunier A; Halftermeyer J; Ablain J; de Reynies A; Peres L; Le Bras M; Metzger D; de Thé H
Blood; 2014 Dec; 124(25):3772-80. PubMed ID: 25258343
[TBL] [Abstract][Full Text] [Related]
8. The DNA binding property of PML/RARA but not the integrity of PML nuclear bodies is indispensable for leukemic transformation.
Liu X; Yuan H; Peres L; Chen S; Chen Z; de The H; Zhou J; Zhu J
PLoS One; 2014; 9(8):e104906. PubMed ID: 25119106
[TBL] [Abstract][Full Text] [Related]
9. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia.
Le Beau MM; Bitts S; Davis EM; Kogan SC
Blood; 2002 Apr; 99(8):2985-91. PubMed ID: 11929790
[TBL] [Abstract][Full Text] [Related]
10. PML nuclear body disruption impairs DNA double-strand break sensing and repair in APL.
di Masi A; Cilli D; Berardinelli F; Talarico A; Pallavicini I; Pennisi R; Leone S; Antoccia A; Noguera NI; Lo-Coco F; Ascenzi P; Minucci S; Nervi C
Cell Death Dis; 2016 Jul; 7(7):e2308. PubMed ID: 27468685
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a humanized APL model via the transplantation of PML-RARA-transduced human common myeloid progenitors into immunodeficient mice.
Matsushita H; Yahata T; Sheng Y; Nakamura Y; Muguruma Y; Matsuzawa H; Tanaka M; Hayashi H; Sato T; Damdinsuren A; Onizuka M; Ito M; Miyachi H; Pandolfi PP; Ando K
PLoS One; 2014; 9(11):e111082. PubMed ID: 25369030
[TBL] [Abstract][Full Text] [Related]
12. Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia.
Dos Santos GA; Kats L; Pandolfi PP
J Exp Med; 2013 Dec; 210(13):2793-802. PubMed ID: 24344243
[TBL] [Abstract][Full Text] [Related]
13. The genetics and clinical characteristics of children morphologically diagnosed as acute promyelocytic leukemia.
Zhao J; Liang JW; Xue HL; Shen SH; Chen J; Tang YJ; Yu LS; Liang HH; Gu LJ; Tang JY; Li BS
Leukemia; 2019 Jun; 33(6):1387-1399. PubMed ID: 30575821
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding.
Schoofs T; Rohde C; Hebestreit K; Klein HU; Göllner S; Schulze I; Lerdrup M; Dietrich N; Agrawal-Singh S; Witten A; Stoll M; Lengfelder E; Hofmann WK; Schlenke P; Büchner T; Hansen K; Berdel WE; Rosenbauer F; Dugas M; Müller-Tidow C
Blood; 2013 Jan; 121(1):178-87. PubMed ID: 23152544
[TBL] [Abstract][Full Text] [Related]
15. Expression profiling of murine acute promyelocytic leukemia cells reveals multiple model-dependent progression signatures.
Walter MJ; Park JS; Lau SK; Li X; Lane AA; Nagarajan R; Shannon WD; Ley TJ
Mol Cell Biol; 2004 Dec; 24(24):10882-93. PubMed ID: 15572690
[TBL] [Abstract][Full Text] [Related]
16. Rara haploinsufficiency modestly influences the phenotype of acute promyelocytic leukemia in mice.
Welch JS; Klco JM; Varghese N; Nagarajan R; Ley TJ
Blood; 2011 Feb; 117(8):2460-8. PubMed ID: 21190992
[TBL] [Abstract][Full Text] [Related]
17. Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure.
Nasr R; Lallemand-Breitenbach V; Zhu J; Guillemin MC; de Thé H
Clin Cancer Res; 2009 Oct; 15(20):6321-6. PubMed ID: 19808868
[TBL] [Abstract][Full Text] [Related]
18. Missense mutations in the PML/RARalpha ligand binding domain in ATRA-resistant As(2)O(3) sensitive relapsed acute promyelocytic leukemia.
Marasca R; Zucchini P; Galimberti S; Leonardi G; Vaccari P; Donelli A; Luppi M; Petrini M; Torelli G
Haematologica; 1999 Nov; 84(11):963-8. PubMed ID: 10553155
[TBL] [Abstract][Full Text] [Related]
19. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice identify cooperating events and genetic pathways to acute promyelocytic leukemia.
Le Beau MM; Davis EM; Patel B; Phan VT; Sohal J; Kogan SC
Blood; 2003 Aug; 102(3):1072-4. PubMed ID: 12689927
[TBL] [Abstract][Full Text] [Related]
20. MIR125B1 represses the degradation of the PML-RARA oncoprotein by an autophagy-lysosomal pathway in acute promyelocytic leukemia.
Zeng CW; Chen ZH; Zhang XJ; Han BW; Lin KY; Li XJ; Wei PP; Zhang H; Li Y; Chen YQ
Autophagy; 2014 Oct; 10(10):1726-37. PubMed ID: 25126724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
